Department of Anesthesiology, The First Medical Center of Chinese PLA General Hospital, Beijing, China.
Medical school of Chinese PLA, Beijing, China.
BMC Anesthesiol. 2021 Dec 20;21(1):318. doi: 10.1186/s12871-021-01535-y.
Laryngeal masks airway (LMA) has been increasingly used in surgical patients. However, the use of LMA in laparoscopic surgeries remains controversial. The major concerns include the potential risk of esophageal regurgitation, aspiration, and difficulties to achieve effective ventilation. The aim of this study was to evaluate the safety and effectiveness of the LMA® Protector™ in patients undergoing laparoscopic surgery.
Patients aged 18 to 70 years, scheduled for laparoscopic surgeries were included. The insertion time, successful insertion rate, and oropharyngeal leak pressure were measured. Airway complications and airway manipulations during the procedure were documented. Effective ventilation rate was calculated. Visible bloodstains and reflux content in the drainage channel were documented after the removal of LMA® Protector™.
Three hundred patients were enrolled. The insertion of LMA® Protector™ failed in seven patients resulting with a successful insertion rate of 97.7%. During the maintenance of anesthesia, airway manipulation was required in 19 patients (19/293, 6.48%), in three of whom the LMA was replaced with endotracheal intubation resulting with an effective ventilation rate of 96.7% (290/300). The oropharyngeal leak pressure was 30.18 ± 5.88 cmHO. Seventy-five patients (25.86%) reported mild sore throat on the first day after surgery. Bloodstains on study devices were noticed in 58 patients (20%). Seventy-five patients (25.86%) reported mild sore throat on the first day after surgery. Gastric reflux was noticed in the drainage tube in 5 patients (1.72%) with no signs of aspiration in any of those patients.
The LMA® Protector™ was shown to be safe and effective in patients undergoing laparoscopic surgeries. Although minor complications that require no further treatment, no clinically diagnosed aspiration was noticed in our study. Gastric reflux was noticed in the drainage tube in five patients undergoing laparoscopic gynecology surgery. Further research is needed to verify whether LMA® Protector™ is suitable for procedures in Trendelenburg position or other situations that a high risk of gastroesophageal reflux exists.
The trial was registered at the Chinese Clinical Trial Registry ( ChiCTR1800018300 , date of registration: September 2018).
喉罩气道(LMA)在外科患者中越来越多地使用。然而,在腹腔镜手术中使用 LMA 仍然存在争议。主要关注的问题包括潜在的食管反流、误吸和难以实现有效通气的风险。本研究的目的是评估 LMA®Protector™ 在腹腔镜手术患者中的安全性和有效性。
纳入年龄在 18 至 70 岁之间、计划接受腹腔镜手术的患者。测量插入时间、成功率和口咽漏压。记录气道并发症和手术过程中的气道操作。计算有效通气率。记录 LMA®Protector™ 取出后引流管中可见的血迹和反流物。
共纳入 300 例患者。7 例患者 LMA®Protector™ 插入失败,成功率为 97.7%。在麻醉维持期间,19 例患者(19/293,6.48%)需要进行气道操作,其中 3 例更换为气管内插管,有效通气率为 96.7%(290/300)。口咽漏压为 30.18±5.88cmH2O。75 例患者(25.86%)术后第一天诉轻度咽痛。58 例患者(20%)在研究器械上发现血迹。75 例患者(25.86%)术后第一天诉轻度咽痛。5 例患者(1.72%)引流管中发现胃反流,但无任何患者发生误吸。
LMA®Protector™ 在腹腔镜手术患者中是安全有效的。虽然有一些需要进一步治疗的轻微并发症,但在我们的研究中没有发现临床诊断的误吸。在接受腹腔镜妇科手术的 5 例患者中,引流管中发现胃反流。需要进一步研究来验证 LMA®Protector™ 是否适用于存在高胃食管反流风险的特伦德伦伯格体位或其他情况。
该试验在中国临床试验注册中心注册(ChiCTR1800018300,注册日期:2018 年 9 月)。